News
Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.
The challenge, open from May 7 to June 7, invites school and university students to design a poster that answers the question ...
KalVista Pharmaceuticals, Inc. today announced that it will present new sebetralstat data at two upcoming congresses taking place concurrently from May 29?June 1, 2025: the 14th C1-inhibitor ...
Rademikibart significantly improved airway function, as measured by FEV1, within a day and significantly reduced acute exacerbations in patients with inflammation-mediated chronic asthma strongly supp ...
Twenty per cent of allergic reactions to food occur in schools, and while some schools are well prepared to deal with the ...
Element 112, LLC dba Madeline’s Pâtisserie Issues Allergy Alert on Undeclared Wheat in Croissants and Croissant Buns ...
Annual Congress, CureGene Pharmaceuticals ("CureGene") announced late-breaking preclinical results for its investigational liver-targeted thyroid hormone receptor beta (THR-β) prodrug, CG-0416.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results